Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes.

The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for three additional one-year periods. Under the Agreement, Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including the Company's premium grade, single-use 720g bicarbonate cartridge, PureCart; liquid acetic acid-based RenalPure®; liquid bicarbonate SteriLyte®; as well as other dialysis related ancillary products.

"Heritage Dialysis has built a care model that demands flexibility and operational consistency," said Tim Chole, Chief Commercial Officer at Rockwell Medical. "This agreement reflects our ability to support dialysis providers with a comprehensive portfolio of products and a supply partnership designed to meet the demands of Heritage Dialysis' sophisticated, multi-environment operations."

"Located across the Wolverine State, our team is on a mission to transform renal care by combining state of the art technology and making available the best treatment plans that will provide better health and wellness," said Ryan Height, BSN, RN, MBA, Founder and CEO at Heritage Dialysis. "We look forward to working with Rockwell Medical because we believe that they truly understand the realities of delivering dialysis across evolving care models and support our long-term growth."